Outcome of a hepatitis C outbreak among patients in a pain management clinic

Digestive Diseases and Sciences

Volumn 55, Issue 6, 2010, Pages 1738-1743

  Fazili, Javid ^a   Mallonee, Sue ^b   Tierney, William M ^a   Bader, Teddy F ^a   Sachdev, Arun K ^c   Bird, Philip C ^d   Schmidt, Robert D ^d   Mesiya, Sikander A ^e   Lackey, Charles L ^d  

^a UNIVERSITY OF OKLAHOMA COLLEGE OF MEDICINE   (United States)

^b OKLAHOMA STATE DEPARTMENT OF HEALTH   (United States)

^c Digestive Disease Specialists Inc   (United States)

^d Private Gastroenterology Practice   (United States)

^e Digestive Disease Specialists Inc   (United States)

Author keywords

Follow up studies; Hepatitis C outbreak; Nosocomial hepatitis; Outcomes assessment; Sustained viral response

Indexed keywords

ALANINE AMINOTRANSFERASE; PEGINTERFERON; RIBAVIRIN;

ADULT; AGED; ANTIVIRAL THERAPY; ARTICLE; CAUCASIAN; CHRONIC DISEASE; CLINICAL ARTICLE; CLINICAL EVALUATION; COHORT ANALYSIS; CONTROLLED STUDY; EPIDEMIC; FEMALE; HEPATITIS C; HEPATITIS C VIRUS; HISTOPATHOLOGY; HUMAN; IMMUNOCOMPROMISED PATIENT; LABORATORY TEST; LIVER BIOPSY; MALE; MEDICAL HISTORY; MEDICAL RECORD REVIEW; OUTCOME ASSESSMENT; OUTPATIENT DEPARTMENT; PAIN; PRIORITY JOURNAL; RETROSPECTIVE STUDY; TREATMENT RESPONSE;

ADULT; AGE FACTORS; AGED; AGED, 80 AND OVER; ANTIVIRAL AGENTS; BIOPSY; CHI-SQUARE DISTRIBUTION; CROSS INFECTION; DISEASE OUTBREAKS; FEMALE; HEPACIVIRUS; HEPATITIS C ANTIBODIES; HEPATITIS C, CHRONIC; HUMANS; INTERFERONS; LIVER; MALE; MIDDLE AGED; OKLAHOMA; PAIN CLINICS; RETROSPECTIVE STUDIES; RIBAVIRIN; RISK ASSESSMENT; RISK FACTORS; RNA, VIRAL; TIME FACTORS; TREATMENT OUTCOME; VIRAL LOAD; YOUNG ADULT;

EID: 77954426837     PISSN: 01632116     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10620-010-1228-z     Document Type: Article

References (28)

1. World Health Organization 1999 Hepatitis C update Wkly Epidemiol Rec 74 425 427
2. JH Hoofnagle 2002 Course and outcome of hepatitis C Hepatology 36 S21 S29 10.1002/hep.1840360704 12407573
3. P Marcellin 1999 Hepatitis C: the clinical spectrum of the disease J Hepatol 31 suppl 1 9 16 10.1016/S0168-8278(99)80368-7 10622554 (Pubitemid 30002685)
4. HJ Alter LB Seeff 2000 Recovery, persistence, and sequelae in hepatitis C virus infection: a perspective on long-term outcome Sem Liver Dis 20 1 17 35 10.1055/s-2000-9505 1:STN:280:DC%2BD3M%2Fit12ltA%3D%3D
5. L Arlic M Fort J Izopet, et al. 2000 Study of host and virus-related factors associated with spontaneous hepatitis C virus clearance Tissue Antigens 56 154 158 10.1034/j.1399-0039.2000.560207.x (Pubitemid 30621282)
6. SA Villano D Vlahov KE Nelson, et al. 1999 Persistence of viremia and the importance of long-term follow-up after acute hepatitis C infection Hepatology 29 3 908 914 10.1002/hep.510290311 1:STN:280:DyaK1M7mt1ertA%3D%3D 10051497 (Pubitemid 29109609)
7. LB Seeff 2002 Natural history of chronic hepatitis C Hepatology 36 S35 S46 10.1002/hep.1840360706 12407575
8. M Wiese F Berr M Lafrenz, et al. 2000 Low frequency of cirrhosis in a hepatitis C (genotype lb) single-source outbreak in Germany: a 20-year multicenter study Hepatology 32 1 91 96 10.1053/jhep.2000.8169 1:STN:280:DC%2BD3czjtVSgug%3D%3D 10869294 (Pubitemid 30432371)
9. H Nomura S Sou H Tanimoto, et al. 2004 Short-term Interferon-alfa therapy for acute hepatitis C: a randomized controlled trial Hepatology 39 5 1213 1219 10.1002/hep.20196 1:CAS:528:DC%2BD2cXks1Sjtrs%3D 15122749 (Pubitemid 38569042)
10. JT Gerlach HM Diepolder R Zachoval, et al. 2003 Acute hepatitis C: high rate of both spontaneous and treatment-induced viral clearance Gastroenterology 125 80 88 10.1016/S0016-5085(03)00668-1 12851873 (Pubitemid 36799109)
11. JT Blackard MT Shata NJ Shire, et al. 2008 Acute hepatits C virus infection: a chronic problem Hepatology 47 1 321 330 10.1002/hep.21902 1:CAS:528:DC%2BD1cXhtlChtrg%3D 18161707 (Pubitemid 351171069)
12. SM Kamal AE Fouly RR Kamel, et al. 2006 Peginterferon alfa-2b therapy in acute hepatitis C, impact of onset of therapy on sustained virologic response Gastroenterology 130 632 638 10.1053/j.gastro.2006.01.034 1:CAS:528: DC%2BD28XjsVylsbw%3D 16530503 (Pubitemid 43374512)
13. G Macedo A Correia T Ribeiro 2003 Antiviral treatment in acute hepatitis C Hepatogastroenterology 50 52 1057 1059 1:CAS:528:DC%2BD3sXlsFajt74%3D 12845981 (Pubitemid 36723842)
14. A Larghi M Zuin A Crosignant, et al. 2002 Outcome of an outbreak of acute hepatitis C among healthy volunteers participating in pharmacokinetics studies Hepatology 36 993 1000 1:CAS:528:DC%2BD38XotlGhsLc%3D 12297849
15. RD Comstock S Mallonee JL Fox, et al. 2004 A large nosocomial outbreak of hepatitis C and hepatitis B among patients receiving pain remediation treatments Infect Control Hosp Epidemiol 25 576 583 10.1086/502442 15301030 (Pubitemid 38954488)
16. A Alberti S Boccato A Vario L Benvegnu 2002 Therapy of acute hepatitis C Hepatology 36 S195 S200 10.1002/hep.1840360725 1:CAS:528:DC%2BD38XovFaksL0%3D 12407594 (Pubitemid 35253481)
17. JCL Booth J O'Grady J Neuberger 2001 Clinical guidelines on the management of hepatitis C Gut 49 suppl. 1 i1 i21 10.1136/gut.49.suppl-1.I1 11413125 (Pubitemid 32601866)
18. DM Patrick MW Tyndall PGA Cornelisse, et al. 2001 Incidence of hepatitis C virus infection among injection drug users during an outbreak of HIV infection CMAJ 165 7 889 895 1:STN:280:DC%2BD3Mrlt1KitA%3D%3D 11599327 (Pubitemid 34028226)
19. A Macedo de Oliveira KL Shite DP Leschinsky, et al. 2005 An outbreak of hepatitis C virus infections among outpatients at a hematology/oncology clinic Ann Intern Med 142 898 902 15941696
20. N Furusyo N Kubo H Nakashima, et al. 2004 Confirmation of nosocomial hepatitis C virus infection in a hemodialysis unit Infect Control Hosp Epidemiol 25 584 590 10.1086/502443 15301031 (Pubitemid 38954489)
21. Centers for Disease Control and Prevention 2004 Transmission of hepatitis B and C virus in outpatient settings-New York, Oklahoma, Nebraska-2000-2002 MMWR 52 38 901 906
22. Centers for Disease Control and Prevention 2008 Acute hepatitis C virus infections attributed to unsafe injection practices at an endoscopy clinic-Nevada, 2007 MMWR 57 19 513 517
23. T Santantonio E Sinisi A Guastadisegni, et al. 2003 Natural course of acute hepatitis C: a long-term prospective study Dig Liver Dis 35 2 104 113 10.1016/S1590-8658(03)00007-0 1:STN:280:DC%2BD3s3isFOjug%3D%3D 12747629 (Pubitemid 41490321)
24. E Jaeckel M Cornberg H Wedemeyer, et al. 2001 Treatment of acute hepatitis C with interferon alfa-2b N Engl J Med 345 20 1452 1457 10.1056/NEJMoa011232 1:CAS:528:DC%2BD3MXovVaqs70%3D 11794193
25. KL Lindsay C Trepo T Heintges, et al. 2001 A randomized, double-blind trial comparing pegylated interferon alfa-2b to interferon alfa-2b as initial treatment for chronic hepatitis C Hepatology 34 2 395 403 10.1053/jhep.2001. 26371 1:CAS:528:DC%2BD3MXmtVGqtLs%3D 11481625 (Pubitemid 32702353)
26. MW Fried ML Shiffman R Reddy, et al. 2002 Peg-interferon alfa-2a plus ribavirin from chronic hepatitis C virus infection N Engl J Med 347 975 982 10.1056/NEJMoa020047 1:CAS:528:DC%2BD38Xnt12rtb0%3D 12324553
27. S Zeuzem SV Feinman J Rasenack, et al. 2000 Peginterferon alfa-2a in patients with chronic hepatitis C N Engl J Med 343 23 1666 1672 10.1056/NEJM200012073432301 1:CAS:528:DC%2BD3cXovVGhurY%3D 11106715
28. MP Manns JG McHutchison SC Gordon, et al. 2001 Peginterferon alfa-2b plus ribavirin compared to interferon alfa-2b plus ribavirin for the treatment of chronic hepatitis C: a randomized trial Lancet 358 958 965 10.1016/S0140- 6736(01)06102-5 1:CAS:528:DC%2BD3MXntF2qtb8%3D 11583749 (Pubitemid 32913521)